|
Dave
Wurtz, who previously worked at Thermo Fisher Scientific Inc,
was appointed vice president, regulatory and quality. He will
work on getting FDA clearances and approvals, marketing new
products, and look into medical-device quality systems.
Daniel Guggenheim, who formerly served as assistant general
counsel at McKesson Corp will be chief compliance officer. He
will make sure that Theranos complies with all state and federal
regulations.
Theranos said its board had also created a compliance and
quality committee.
The company, once valued at $9 billion, was founded by Elizabeth
Holmes in 2003 to develop an innovative blood testing device
that would give quicker results using just one drop of blood.
Its fortunes, however, waned after the Wall Street Journal
published a series of articles starting in October last year
that suggested the devices were flawed and inaccurate.
Earlier this month, Holmes was barred from owning or operating a
lab for at least two years.
(Reporting by Anya George Tharakan in Bengaluru; Editing by
Sayantani Ghosh)
[© 2016 Thomson Reuters. All rights
reserved.] Copyright 2016 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
 |
|
